BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38240702)

  • 1. Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer.
    Xie T; Fu DJ; Li KJ; Guo JD; Xiao ZM; Li Z; Zhao SC
    Aging (Albany NY); 2024 Jan; 16(2):1581-1604. PubMed ID: 38240702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
    Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W
    Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
    Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
    Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a basement membrane-related gene signature for predicting prognosis and estimating the tumor immune microenvironment in breast cancer.
    Cai J; Zhang X; Xie W; Li Z; Liu W; Liu A
    Front Endocrinol (Lausanne); 2022; 13():1065530. PubMed ID: 36531485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
    Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
    Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
    Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
    Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer.
    Xiong Y; Kong X; Mei H; Wang J; Zhou S
    Sci Rep; 2023 Dec; 13(1):22218. PubMed ID: 38097783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of basement membrane-related genes in a risk signature for prognosis in clear cell renal cell carcinoma.
    Xia B; Wang J; Zhang D; Hu X
    Sci Rep; 2024 Feb; 14(1):3893. PubMed ID: 38365923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer.
    Han C; Deng Y; Yang B; Hu P; Hu B; Wang T; Liu J; Xia Q; Liu X
    Front Immunol; 2023; 14():1126902. PubMed ID: 36891298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma.
    Yao K; Zhang R; Li L; Liu M; Feng S; Yan H; Zhang Z; Xie D
    Front Immunol; 2023; 14():1181370. PubMed ID: 37600770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
    Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
    Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.
    Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L
    Front Immunol; 2022; 13():777724. PubMed ID: 35154101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
    Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
    Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basement membrane-related gene signature is associated with immunity and predicts survival accurately in hepatocellular carcinoma.
    Zhao Y; Yin Z; Huang K; Zhang F; Chen Y; Deng Y; Chen H
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5751-5760. PubMed ID: 36575345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
    Liu ZY; Xin L
    Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
    Lyu F; Li Y; Yan Z; He Q; Cheng L; Zhang P; Liu B; Liu C; Song Y; Xing Y
    J Transl Med; 2022 May; 20(1):202. PubMed ID: 35538543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.